Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Ecron Acunova has acquired majority stake in aCROnordic, a full service contract research organization covering Denmark, Sweden, Finland and Norway.
Subscribe to our email newsletter
Soren Stroh, founder and previous owner, continues his role as CEO of aCROnordic for Nordic region.
aCROnordic is a provider of drug and medical device development services to pharmaceutical and medical device companies and to investors and biotech companies.
The company’s clinical expertise is especially strong within neurology, oncology and cardiology.
In addition to clinical research services, aCROnordic renders services in cross-functional drug development with focus on early development and regulatory strategy.
Ecron Acunova founder and chairman DA Prasanna said the merger of EA and aCROnordic, both having decades of track record, an excellent reputation and deep local knowledge in their geographies, yields substantial synergy to both of them for serving their clients’ needs.